Literature DB >> 19245532

The incidence of idiopathic thrombocytopenic purpura among adults: a population-based study and literature review.

Page E Abrahamson1, Susan A Hall, Maurille Feudjo-Tepie, Fanny S Mitrani-Gold, John Logie.   

Abstract

Published data on the epidemiology of idiopathic thrombocytopenic purpura (ITP) among adults are very limited. We conducted a study of ITP incidence using the General Practice Research Database in the United Kingdom. From 1992 to 2005, there were 840 cases of ITP among adults considering 21 749 623 person-years (PYs) of follow-up, for a crude incidence of 3.9 per 100 000 PYs [95% confidence interval (CI): 3.6, 4.1]. The incidence was higher among women [4.5 per 100 000 PYs (95% CI: 4.2, 4.9)] than men [3.2 per 100 000 PYs (95% CI: 2.8, 3.5)]. Among both women and men, incidence was higher at older ages and in later study years. In a systematic review of previously published literature, incidence of ITP among adults ranged from 1.6 to 2.68 per 100 000 persons per year; prevalence ranged from 9.5 to 23.6 per 100 000 persons. In order to improve the understanding of the disease burden of ITP, future studies should include a clearly defined definition of ITP and focus on well-described source populations that are geographically and ethnically diverse.

Entities:  

Mesh:

Year:  2009        PMID: 19245532     DOI: 10.1111/j.1600-0609.2009.01247.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  30 in total

Review 1.  Immune thrombocytopenia: no longer 'idiopathic'.

Authors:  Keith McCrae
Journal:  Cleve Clin J Med       Date:  2011-06       Impact factor: 2.321

2.  [Primary immune thrombocytopenia in adults: diagnostics and treatment consensus statement of the Austrian Society of Hematology and Oncology (ÖGHO)].

Authors:  Ingrid Pabinger; Günther Gastl; Michael Steurer; Siegfried Sormann; Michael Fillitz; Josef Friedl; Dietmar Geissler; Klaus Geissler; Richard Greil; Paul Knöbl; Sibylle Kozek-Langenecker; Peter Krippl; Paul Kyrle; Alois Lang; Werner Linkesch; Heinz Ludwig; Markus Müller; Simon Panzer; Elisabeth Pittermann; Josef Thaler; Ansgar Weltermann
Journal:  Wien Klin Wochenschr       Date:  2012-03-03       Impact factor: 1.704

3.  Immune thrombocytopenia in adults: a prospective cohort study of clinical features and predictors of outcome.

Authors:  Lamiae Grimaldi-Bensouda; Clémentine Nordon; Marc Michel; Jean-François Viallard; Daniel Adoue; Nadine Magy-Bertrand; Jean-Marc Durand; Philippe Quittet; Olivier Fain; Bernard Bonnotte; Anne-Sophie Morin; Nathalie Morel; Nathalie Costedoat-Chalumeau; Brigitte Pan-Petesch; Mehdi Khellaf; Antoinette Perlat; Karim Sacre; François Lefrere; Lucien Abenhaim; Bertrand Godeau
Journal:  Haematologica       Date:  2016-05-26       Impact factor: 9.941

Review 4.  Epidemiology of primary immune thrombocytopenia in children and adults in Japan: a population-based study and literature review.

Authors:  Yoshiyuki Kurata; Kingo Fujimura; Masataka Kuwana; Yoshiaki Tomiyama; Mitsuru Murata
Journal:  Int J Hematol       Date:  2011-02-24       Impact factor: 2.490

5.  Romiplostim for the treatment of chronic immune thrombocytopenia in adult Japanese patients: a double-blind, randomized Phase III clinical trial.

Authors:  Yukari Shirasugi; Kiyoshi Ando; Koji Miyazaki; Yoshiaki Tomiyama; Shinichiro Okamoto; Mineo Kurokawa; Keita Kirito; Yuji Yonemura; Shinichiro Mori; Kensuke Usuki; Koji Iwato; Satoshi Hashino; Helen Wei; Richard Lizambri
Journal:  Int J Hematol       Date:  2011-06-25       Impact factor: 2.490

6.  Splenectomy vs. rituximab as a second-line therapy in immune thrombocytopenic purpura: a single center experience.

Authors:  Ahmed S Al Askar; Naila A Shaheen; Mohsen Al Zahrani; Mohammed G Al Otaibi; Bader S Al Qahtani; Faris Ahmed; Mohand Al Zughaibi; Ismat Kamran; May Anne Mendoza; Altaf Khan
Journal:  Int J Hematol       Date:  2017-09-11       Impact factor: 2.490

Review 7.  Eltrombopag: a review of its use in treatment-refractory chronic primary immune thrombocytopenia.

Authors:  Karly P Garnock-Jones
Journal:  Drugs       Date:  2011-07-09       Impact factor: 9.546

8.  Immune thrombocytopenic purpura might be an early hematologic manifestation of undiagnosed human immunodeficiency virus infection.

Authors:  Shih-Wei Lai; Hsien-Feng Lin; Cheng-Li Lin; Kuan-Fu Liao
Journal:  Intern Emerg Med       Date:  2016-08-25       Impact factor: 3.397

9.  American Society of Hematology 2019 guidelines for immune thrombocytopenia.

Authors:  Cindy Neunert; Deirdra R Terrell; Donald M Arnold; George Buchanan; Douglas B Cines; Nichola Cooper; Adam Cuker; Jenny M Despotovic; James N George; Rachael F Grace; Thomas Kühne; David J Kuter; Wendy Lim; Keith R McCrae; Barbara Pruitt; Hayley Shimanek; Sara K Vesely
Journal:  Blood Adv       Date:  2019-12-10

10.  Idiopathic thrombocytopenic purpura during pregnancy.

Authors:  Gonçalo Inocêncio; Lúcia Coutinho; Graça Buchner; Rosa Zulmira
Journal:  BMJ Case Rep       Date:  2013-01-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.